| Name | Title | Contact Details |
|---|
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
Patient Interaction is a Bronx, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Foresight Corporation is a Dublin, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Germer International is a Blue Bell, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Dauterman Medical is a Aiea, HI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.